Handbook of Disease Burdens and Quality of Life Measures pp 1825-1837 | Cite as
Hirsutism and Quality of Life
Hirsutism in women results in significant psychological and social problems. It impacts negatively upon the quality of life of women and is the cause of stress, anxiety and depression, particularly in cultures where hairlessness is viewed as the norm for women. Facially hirsute women perceive themselves to be in poorer health than non-hirsute women, and there are fewer in employment despite having similar educational experiences and levels of attainment.
Hirsute women spend much time and effort in removing excess facial: and can feel overwhelmed and frustrated by their efforts. All currently available treatments have limited effectiveness and can have serious side-effects. It is therefore a testament to the levels of distress caused by the problem that women persist with treatment despite the difficulties encountered.
There is very limited evidence as to the cost-effectiveness of the various treatments for hirsutism but the evidence that does exist indicates that the use eflornithine cream results in a small gain in Quality Adjusted Life Years ( QALYs) for patients and provides acceptable value for money.
When women and their partners were asked to consider what they would be willing to pay for an effective treatment for hirsutism, the average amounts were £40 and £47 per month respectively which is more than is currently spent on alternatives by women with the condition.
It is essential that research continues to be undertaken into this distressing problem and that clinicians who treat women with hirsutism deal with them sensitively, acknowledging the major psychological and emotional difficulties these women are facing.
KeywordsPolycystic Ovary Syndrome Hair Growth Hair Removal Facial Hair Hirsute Woman
List of Abbreviations:
British Association of Dermatologists
Drug and Therapeutics Bulletin
Food and Drugs Administration
health related quality of life
primary care dermatology society
polycystic ovary syndrome
quality adjusted life year
visual analogue scale
willingness to pay
- British Association of Dermatologists. (2006). Available at: http://www.bad.org.uk/public/leaflets/hirsutism.asp (Accessed: February 20, 2008).
- Ching HL, Burke V, Stuckey BG. (2007). Clin Endocrinol. 66(3): 373–379.Google Scholar
- Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. (2005). Br J Dermatol. 152: 986–992.Google Scholar
- Drug and Therapeutics Bulletin (DTB). (2001). 39: 1–5.Google Scholar
- Givens JR, Kurtz BR. (1992). Hirsutism, virilization, and androgen excess. In: Hurst JW, Ambrose SS, et al. (eds.) Medicine for the Practicing Physician, 3rd ed. Butterworth-Heinemann, Boston, pp. 568–571.Google Scholar
- Goodheart HP, Uyttendaele HI. (2008). Available at: http://www.emedicine.com/derm/topic472.htm (Accessed: February 20 2008).
- Griffing GT. (2007). Available at: http://www.emedicine.com/med/topic1017.htm (Accessed: February 20 2008).
- Hamzavi I, Tan E, Shapiro J, Lui H. (2003). Lasers Surg Med. 15: 32.Google Scholar
- Hopkinson ZEC, Sattar N, Fleming R, Greer IA. (1998). Br Med J. 317: 329–332.Google Scholar
- Hunter MH, Carek PJ. (2003). Am Fam Physician. 67 Available at: http://www.aafp.org/afp/20030615/2565.html (Accessed: February 20, 2008).
- National Horizon Scanning Centre: New and Emerging Technology Briefing. (2001). Available at: http://www.pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/2001reports/Eflornithine.PDF (Accessed February 20 2008).
- Primary Care Dermatology Society (PCDS). (2005). Guidelines: Medical Management of Hirsutism.Available at: (http://www.evidence-based-medicine.co.uk/guidelines.html)
- Smith SR, Piacquadio D, Beger B. (2003). Abstract from the 61st Annual Meeting of the American Academy of Dermatology. San Francisco, CA.Google Scholar
- Soliman N, Wardle P. (2006). Available at: http://student.bmj.com/issues/06/10/education/360.php (Accessed: February 20, 2008).
- Towse A, Pritchard C. (2002). Does NICE have a threshold? An external view. In: Costeffectiveness Thresholds: Economic and Ethical Issues. Office of Health Economics, London, UK.Google Scholar
- Walling AD. (2004). Am Fam Physician. 69. Available at: (http://www.aafp.org/afp/20040115/tips/17.html) (Accessed: February 20, 2008).